NSUN2 regulates PARP9 progression through m5C modification to mediate breast cancer progression. [PDF]
Li X +7 more
europepmc +1 more source
Hypoxia-induced exosomal LNCOC1 orchestrates bladder cancer progression via the YBX1/PIK3CA axis and serves as a potential liquid biopsy biomarker. [PDF]
Xu H +9 more
europepmc +1 more source
METTL14-Mediated m6A Modification of NEAT1_2 Releases YBX1 From Paraspeckles to Exacerbate Periodontitis. [PDF]
Du J +6 more
europepmc +1 more source
Background: Hepatocellular carcinoma (HCC) is an aggressive, largely chemo-resistant cancer with a poor prognosis and is the leading cause of cancer-related deaths worldwide. Currently, there is no effective systemic chemotherapy for HCC.
Hussain, Shaibir +6 more
core
8-Oxoguanine Modified CircMTUS1 Drives PABPC1 Phase Separation to Promote Gastric Cancer Progression and Cisplatin Resistance via Autophagy. [PDF]
Peng L +8 more
europepmc +1 more source
ETV4 Improves Cerebral Ischemia-Reperfusion Injury by Restraining YBX1-GPX4-Ferroptosis Cascades. [PDF]
Xu Q, Deng F, Yu D.
europepmc +1 more source
Prolactin-Releasing Hormone Receptor (PRLHR) enhances radiosensitivity and exacerbates DNA damage in glioblastoma post-irradiation by inhibiting Y-box-binding protein-1 (YBX1) nuclear translocation: a novel perspective on precision radiotherapy. [PDF]
Qiu Y +9 more
europepmc +1 more source
YBX1 Expression Marks Proliferative Tumour States with Context-Dependent Genomic Instability: A Pan-Cancer Analysis. [PDF]
Wang S +8 more
europepmc +1 more source
Coordinated DNA 5-mC and RNA m<sup>5</sup>C methylation epigenetically regulates MZF1 splice variants to drive EGFR-TKI resistance. [PDF]
Zhang H +8 more
europepmc +1 more source
A Single-Cell Multiomics Pipeline Maps YBX1 as a Functional Biomarker for Immune Evasion and Therapeutic Resistance in Prostate Adenocarcinoma. [PDF]
Luo C, Lin D, Yang J, Cui K, Chen Z.
europepmc +1 more source

